Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol C Cheung

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
American Journal of Clinical Pathology|October 17, 2014
Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee for High Complexity Testing/Immunohistochemistry: guidelines for the preparation, release, and storage of unstained archived diagnostic tissue sections for immunohistochemistryCarol C Cheung, Diponkar Banerjee, Penny J Barnes, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 13, 2016
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4: Tissue Tools for Quality Assurance in ImmunohistochemistryCarol C Cheung, Corrado D'Arrigo, Manfred Dietel, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 16, 2023
Canadian Multicentric Pan-TRK (CANTRK) Immunohistochemistry Harmonization StudyMartin D Hyrcza, Sebastiao N Martins-Filho, Alan Spatz, et al.
Lung Cancer (Amsterdam, Netherlands)|September 11, 2021
Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancerCarol C Cheung, Adam C Smith, Roula Albadine, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 5, 2019
Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP)Carol C Cheung, Penny Barnes, Gilbert Bigras, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 7, 2019
"Interchangeability" of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracyEmina Torlakovic, Hyun J Lim, Julien Adam, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|January 21, 2026
Oculomics and AI: The Eye as a biomarker for health spanJoy Le Yi Wong, Haoran Cheng, Wen Jun Peh, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
American Journal of Clinical Pathology|October 17, 2014
Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee for High Complexity Testing/Immunohistochemistry: guidelines for the preparation, release, and storage of unstained archived diagnostic tissue sections for immunohistochemistryCarol C Cheung, Diponkar Banerjee, Penny J Barnes, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 13, 2016
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4: Tissue Tools for Quality Assurance in ImmunohistochemistryCarol C Cheung, Corrado D'Arrigo, Manfred Dietel, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 16, 2023
Canadian Multicentric Pan-TRK (CANTRK) Immunohistochemistry Harmonization StudyMartin D Hyrcza, Sebastiao N Martins-Filho, Alan Spatz, et al.
Lung Cancer (Amsterdam, Netherlands)|September 11, 2021
Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancerCarol C Cheung, Adam C Smith, Roula Albadine, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 5, 2019
Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP)Carol C Cheung, Penny Barnes, Gilbert Bigras, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 7, 2019
"Interchangeability" of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracyEmina Torlakovic, Hyun J Lim, Julien Adam, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|January 21, 2026
Oculomics and AI: The Eye as a biomarker for health spanJoy Le Yi Wong, Haoran Cheng, Wen Jun Peh, et al.
Pageof 4